Man Group PLC Amgen Inc Call Options Transaction History

Man Group PLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $3.12 Million - $3.41 Million	10,100 Added 72.66%	24,000 $7.73 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $2.39 Million - $2.91 Million	9,100 Added 189.58%	13,900 $4.34 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $672,175 - $811,400	2,500 Added 108.7%	4,800 $1.36 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $588,110 - $663,458	2,300 New	2,300 $662,000

3,125

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.